Aaron C S, Harbach P R, Wiser S K, Grzegorczyk C R, Smith A L
Genetic Toxicology Research, Upjohn Company, Kalamazoo, MI 49001.
Mutat Res. 1989 Jun;223(2):163-9. doi: 10.1016/0165-1218(89)90044-x.
The in vitro unscheduled DNA synthesis assay (UDS) is part of the routine genetic toxicology screening at The Upjohn Company. The purpose of this paper is to report results for 8 compounds which were tested in the in-house genetic toxicology program. These compounds represent diverse chemical structure and most of them entered the screening program because they are biologically active in efficacy screens. All tests were carried out under Good Laboratory Practices Regulations of the U.S. Food and Drug Administration. None of the materials reported here produced an increase in UDS and therefore the UDS results with these compounds do not suggest potential for genotoxicity.
体外非预定DNA合成试验(UDS)是Upjohn公司常规遗传毒理学筛选的一部分。本文旨在报告在内部遗传毒理学项目中测试的8种化合物的结果。这些化合物代表了不同的化学结构,其中大多数进入筛选项目是因为它们在药效筛选中具有生物活性。所有测试均按照美国食品药品监督管理局的良好实验室规范条例进行。此处报告的所有物质均未使UDS增加,因此这些化合物的UDS结果并不表明其具有遗传毒性潜力。